EFGARTIGIMOD ALFA 20 MG/ML SOL INJ FR 20 ML IV
TED · 810519-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€881,486 · 881,485.92 EUR
WinnerArgenx Spain S.L. – Sucursal em Portugal
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Cencora 3Pl Portugal, S.A. | 3 | €3,693,591 | 2026-11-16 |
| Brainlab Sales GmbH | 2 | €2,619,329 | 2026-10-08 |
| Cencora 3PL Portugal, S.A. | 2 | €1,435,097 | 2026-10-28 |
| ROCHE FARMACÊUTICA QUÍMICA, LDA. | 2 | €1,240,039 | 2026-10-29 |
| Pierre Fabre Medicament Portugal, Lda. | 2 | €748,088 | 2026-11-09 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição de Efgartigimod alfa 20 mg/ml Sol inj Fr 20 ml IV